Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel
Objective Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge. Methods Data were collected retrospectively from patients treated in Veteran Affairs hospitals in Ohio, US...
Gespeichert in:
Veröffentlicht in: | Journal of digestive diseases 2014-04, Vol.15 (4), p.195-201 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 201 |
---|---|
container_issue | 4 |
container_start_page | 195 |
container_title | Journal of digestive diseases |
container_volume | 15 |
creator | Cuschieri, Justin R Drawz, Paul Falck-Ytter, Yngve Wong, Richard C K |
description | Objective
Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge.
Methods
Data were collected retrospectively from patients treated in Veteran Affairs hospitals in Ohio, USA, from 2001 to 2008 with a primary diagnosis of MI (International Classification of Diseases, 9th Revision) and a prescription for clopidogrel filled within 48 h of discharge. Primary outcome was acute GI bleeding after discharge.
Results
Acute GI bleeding occurred in 107 of 3218 patients. Bleeding occurred in those who were elder (66.2 vs 62.4 years, P = 0.0002), had lower glomerular filtration rate (74 vs 81 mL/min, P = 0.024), had filled prescription for warfarin (15.9% vs 6.9%, P = 0.0004), diagnosed as atrial fibrillation (20.6% vs 11.1%, P = 0.003), chronic liver (5.6% vs 2.2%, P = 0.018) or kidney disease (29.0% vs 19.4%, P = 0.016). A risk model and GI bleed risk score were developed and showed that patients with age >65 years, use of warfarin, the presence of chronic liver or kidney disease were at increased risk for GI bleeding.
Conclusions
Veterans patients of advanced age, using warfarin and with chronic liver and kidney disease may be at increased risk of GI bleeding when prescribed clopidogrel following MI. A scoring system may help to identify patients at high risk for GI bleeding. |
doi_str_mv | 10.1111/1751-2980.12123 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1508426321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3786252841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4093-4a14c44e63e32a7517cec11353d3a16d81d188cffbfe77af1f112ccb6c7ea3f13</originalsourceid><addsrcrecordid>eNqFkc9vFCEcxYnR2Fo9ezMkXryMHX5Pj2arrUmjSVP1SBjmy0rLDiMwrnv2H5dx2z14kQsP-LyXfHkIvSTtW1LXKVGCNPSsq0dKKHuEjg83jw9a0SP0LOfbthVSdfIpOqKcKSY4PUa_r32-w87YElPGLiZs7FwAr00uKfqxQC5-NAH3AWDw47oyIcTtoja7aE0afH31ozPJFh_HKvFPKJDMiCdTPIwl4-33iE0CPCXINvkeBmxDnPwQ1wnCc_TEmZDhxf1-gr58eH-zumyuPl98XL27aixvz1jDDeGWc5AMGDV1NGXBEsIEG5ghcujIQLrOOtc7UMo44gih1vbSKjDMEXaC3uxzpxR_zHUwvfHZQghmhDhnTUTbcSoZXdDX_6C3cU71HyqlWkm56ASt1OmesinmnMDpKfmNSTtNWr30o5cG9NKG_ttPdby6z537DQwH_qGQCog9sPUBdv_L06vz84fgZu_zucCvg8-kOy0VU0J_-3Shry9Z91XKG83ZH90Vq6U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706245852</pqid></control><display><type>article</type><title>Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cuschieri, Justin R ; Drawz, Paul ; Falck-Ytter, Yngve ; Wong, Richard C K</creator><creatorcontrib>Cuschieri, Justin R ; Drawz, Paul ; Falck-Ytter, Yngve ; Wong, Richard C K</creatorcontrib><description>Objective
Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge.
Methods
Data were collected retrospectively from patients treated in Veteran Affairs hospitals in Ohio, USA, from 2001 to 2008 with a primary diagnosis of MI (International Classification of Diseases, 9th Revision) and a prescription for clopidogrel filled within 48 h of discharge. Primary outcome was acute GI bleeding after discharge.
Results
Acute GI bleeding occurred in 107 of 3218 patients. Bleeding occurred in those who were elder (66.2 vs 62.4 years, P = 0.0002), had lower glomerular filtration rate (74 vs 81 mL/min, P = 0.024), had filled prescription for warfarin (15.9% vs 6.9%, P = 0.0004), diagnosed as atrial fibrillation (20.6% vs 11.1%, P = 0.003), chronic liver (5.6% vs 2.2%, P = 0.018) or kidney disease (29.0% vs 19.4%, P = 0.016). A risk model and GI bleed risk score were developed and showed that patients with age >65 years, use of warfarin, the presence of chronic liver or kidney disease were at increased risk for GI bleeding.
Conclusions
Veterans patients of advanced age, using warfarin and with chronic liver and kidney disease may be at increased risk of GI bleeding when prescribed clopidogrel following MI. A scoring system may help to identify patients at high risk for GI bleeding.</description><identifier>ISSN: 1751-2972</identifier><identifier>EISSN: 1751-2980</identifier><identifier>DOI: 10.1111/1751-2980.12123</identifier><identifier>PMID: 24373542</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Acute Disease ; Age Factors ; Aged ; Anticoagulants - adverse effects ; Chronic Disease ; clopidogrel ; Female ; gastrointestinal hemorrhage ; Gastrointestinal Hemorrhage - chemically induced ; Gastrointestinal Hemorrhage - epidemiology ; Heart attacks ; Hemorrhage ; Humans ; Kaplan-Meier Estimate ; Kidney diseases ; Kidney Diseases - complications ; Kidney Diseases - epidemiology ; Liver Diseases - complications ; Liver Diseases - epidemiology ; Male ; Middle Aged ; myocardial infarction ; Myocardial Infarction - drug therapy ; Myocardial Infarction - epidemiology ; Ohio - epidemiology ; Platelet Aggregation Inhibitors - adverse effects ; Platelet Aggregation Inhibitors - therapeutic use ; Retrospective Studies ; Risk Assessment - methods ; risk factor ; Risk Factors ; Ticlopidine - adverse effects ; Ticlopidine - analogs & derivatives ; Ticlopidine - therapeutic use ; veteran ; Veterans - statistics & numerical data ; Warfarin - adverse effects</subject><ispartof>Journal of digestive diseases, 2014-04, Vol.15 (4), p.195-201</ispartof><rights>2013 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd</rights><rights>2013 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.</rights><rights>Journal of Digestive Diseases © 2014 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4093-4a14c44e63e32a7517cec11353d3a16d81d188cffbfe77af1f112ccb6c7ea3f13</citedby><cites>FETCH-LOGICAL-c4093-4a14c44e63e32a7517cec11353d3a16d81d188cffbfe77af1f112ccb6c7ea3f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1751-2980.12123$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1751-2980.12123$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24373542$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cuschieri, Justin R</creatorcontrib><creatorcontrib>Drawz, Paul</creatorcontrib><creatorcontrib>Falck-Ytter, Yngve</creatorcontrib><creatorcontrib>Wong, Richard C K</creatorcontrib><title>Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel</title><title>Journal of digestive diseases</title><addtitle>Journal of Digestive Diseases</addtitle><description>Objective
Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge.
Methods
Data were collected retrospectively from patients treated in Veteran Affairs hospitals in Ohio, USA, from 2001 to 2008 with a primary diagnosis of MI (International Classification of Diseases, 9th Revision) and a prescription for clopidogrel filled within 48 h of discharge. Primary outcome was acute GI bleeding after discharge.
Results
Acute GI bleeding occurred in 107 of 3218 patients. Bleeding occurred in those who were elder (66.2 vs 62.4 years, P = 0.0002), had lower glomerular filtration rate (74 vs 81 mL/min, P = 0.024), had filled prescription for warfarin (15.9% vs 6.9%, P = 0.0004), diagnosed as atrial fibrillation (20.6% vs 11.1%, P = 0.003), chronic liver (5.6% vs 2.2%, P = 0.018) or kidney disease (29.0% vs 19.4%, P = 0.016). A risk model and GI bleed risk score were developed and showed that patients with age >65 years, use of warfarin, the presence of chronic liver or kidney disease were at increased risk for GI bleeding.
Conclusions
Veterans patients of advanced age, using warfarin and with chronic liver and kidney disease may be at increased risk of GI bleeding when prescribed clopidogrel following MI. A scoring system may help to identify patients at high risk for GI bleeding.</description><subject>Acute Disease</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Anticoagulants - adverse effects</subject><subject>Chronic Disease</subject><subject>clopidogrel</subject><subject>Female</subject><subject>gastrointestinal hemorrhage</subject><subject>Gastrointestinal Hemorrhage - chemically induced</subject><subject>Gastrointestinal Hemorrhage - epidemiology</subject><subject>Heart attacks</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Kidney diseases</subject><subject>Kidney Diseases - complications</subject><subject>Kidney Diseases - epidemiology</subject><subject>Liver Diseases - complications</subject><subject>Liver Diseases - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>myocardial infarction</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Ohio - epidemiology</subject><subject>Platelet Aggregation Inhibitors - adverse effects</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Retrospective Studies</subject><subject>Risk Assessment - methods</subject><subject>risk factor</subject><subject>Risk Factors</subject><subject>Ticlopidine - adverse effects</subject><subject>Ticlopidine - analogs & derivatives</subject><subject>Ticlopidine - therapeutic use</subject><subject>veteran</subject><subject>Veterans - statistics & numerical data</subject><subject>Warfarin - adverse effects</subject><issn>1751-2972</issn><issn>1751-2980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9vFCEcxYnR2Fo9ezMkXryMHX5Pj2arrUmjSVP1SBjmy0rLDiMwrnv2H5dx2z14kQsP-LyXfHkIvSTtW1LXKVGCNPSsq0dKKHuEjg83jw9a0SP0LOfbthVSdfIpOqKcKSY4PUa_r32-w87YElPGLiZs7FwAr00uKfqxQC5-NAH3AWDw47oyIcTtoja7aE0afH31ozPJFh_HKvFPKJDMiCdTPIwl4-33iE0CPCXINvkeBmxDnPwQ1wnCc_TEmZDhxf1-gr58eH-zumyuPl98XL27aixvz1jDDeGWc5AMGDV1NGXBEsIEG5ghcujIQLrOOtc7UMo44gih1vbSKjDMEXaC3uxzpxR_zHUwvfHZQghmhDhnTUTbcSoZXdDX_6C3cU71HyqlWkm56ASt1OmesinmnMDpKfmNSTtNWr30o5cG9NKG_ttPdby6z537DQwH_qGQCog9sPUBdv_L06vz84fgZu_zucCvg8-kOy0VU0J_-3Shry9Z91XKG83ZH90Vq6U</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Cuschieri, Justin R</creator><creator>Drawz, Paul</creator><creator>Falck-Ytter, Yngve</creator><creator>Wong, Richard C K</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel</title><author>Cuschieri, Justin R ; Drawz, Paul ; Falck-Ytter, Yngve ; Wong, Richard C K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4093-4a14c44e63e32a7517cec11353d3a16d81d188cffbfe77af1f112ccb6c7ea3f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Acute Disease</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Anticoagulants - adverse effects</topic><topic>Chronic Disease</topic><topic>clopidogrel</topic><topic>Female</topic><topic>gastrointestinal hemorrhage</topic><topic>Gastrointestinal Hemorrhage - chemically induced</topic><topic>Gastrointestinal Hemorrhage - epidemiology</topic><topic>Heart attacks</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Kidney diseases</topic><topic>Kidney Diseases - complications</topic><topic>Kidney Diseases - epidemiology</topic><topic>Liver Diseases - complications</topic><topic>Liver Diseases - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>myocardial infarction</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Ohio - epidemiology</topic><topic>Platelet Aggregation Inhibitors - adverse effects</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Retrospective Studies</topic><topic>Risk Assessment - methods</topic><topic>risk factor</topic><topic>Risk Factors</topic><topic>Ticlopidine - adverse effects</topic><topic>Ticlopidine - analogs & derivatives</topic><topic>Ticlopidine - therapeutic use</topic><topic>veteran</topic><topic>Veterans - statistics & numerical data</topic><topic>Warfarin - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cuschieri, Justin R</creatorcontrib><creatorcontrib>Drawz, Paul</creatorcontrib><creatorcontrib>Falck-Ytter, Yngve</creatorcontrib><creatorcontrib>Wong, Richard C K</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of digestive diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cuschieri, Justin R</au><au>Drawz, Paul</au><au>Falck-Ytter, Yngve</au><au>Wong, Richard C K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel</atitle><jtitle>Journal of digestive diseases</jtitle><addtitle>Journal of Digestive Diseases</addtitle><date>2014-04</date><risdate>2014</risdate><volume>15</volume><issue>4</issue><spage>195</spage><epage>201</epage><pages>195-201</pages><issn>1751-2972</issn><eissn>1751-2980</eissn><abstract>Objective
Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge.
Methods
Data were collected retrospectively from patients treated in Veteran Affairs hospitals in Ohio, USA, from 2001 to 2008 with a primary diagnosis of MI (International Classification of Diseases, 9th Revision) and a prescription for clopidogrel filled within 48 h of discharge. Primary outcome was acute GI bleeding after discharge.
Results
Acute GI bleeding occurred in 107 of 3218 patients. Bleeding occurred in those who were elder (66.2 vs 62.4 years, P = 0.0002), had lower glomerular filtration rate (74 vs 81 mL/min, P = 0.024), had filled prescription for warfarin (15.9% vs 6.9%, P = 0.0004), diagnosed as atrial fibrillation (20.6% vs 11.1%, P = 0.003), chronic liver (5.6% vs 2.2%, P = 0.018) or kidney disease (29.0% vs 19.4%, P = 0.016). A risk model and GI bleed risk score were developed and showed that patients with age >65 years, use of warfarin, the presence of chronic liver or kidney disease were at increased risk for GI bleeding.
Conclusions
Veterans patients of advanced age, using warfarin and with chronic liver and kidney disease may be at increased risk of GI bleeding when prescribed clopidogrel following MI. A scoring system may help to identify patients at high risk for GI bleeding.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>24373542</pmid><doi>10.1111/1751-2980.12123</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1751-2972 |
ispartof | Journal of digestive diseases, 2014-04, Vol.15 (4), p.195-201 |
issn | 1751-2972 1751-2980 |
language | eng |
recordid | cdi_proquest_miscellaneous_1508426321 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Acute Disease Age Factors Aged Anticoagulants - adverse effects Chronic Disease clopidogrel Female gastrointestinal hemorrhage Gastrointestinal Hemorrhage - chemically induced Gastrointestinal Hemorrhage - epidemiology Heart attacks Hemorrhage Humans Kaplan-Meier Estimate Kidney diseases Kidney Diseases - complications Kidney Diseases - epidemiology Liver Diseases - complications Liver Diseases - epidemiology Male Middle Aged myocardial infarction Myocardial Infarction - drug therapy Myocardial Infarction - epidemiology Ohio - epidemiology Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Retrospective Studies Risk Assessment - methods risk factor Risk Factors Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use veteran Veterans - statistics & numerical data Warfarin - adverse effects |
title | Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T07%3A00%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20acute%20gastrointestinal%20bleeding%20following%20myocardial%20infarction%20in%20veteran%20patients%20who%20are%20prescribed%20clopidogrel&rft.jtitle=Journal%20of%20digestive%20diseases&rft.au=Cuschieri,%20Justin%20R&rft.date=2014-04&rft.volume=15&rft.issue=4&rft.spage=195&rft.epage=201&rft.pages=195-201&rft.issn=1751-2972&rft.eissn=1751-2980&rft_id=info:doi/10.1111/1751-2980.12123&rft_dat=%3Cproquest_cross%3E3786252841%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706245852&rft_id=info:pmid/24373542&rfr_iscdi=true |